| REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet | Belfast Health and Social Care Trust | Not published | Not published |
| Utathera 7400MBq/20.5-25ml solution | CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | Not published | Not published |
| solution for infusion vial | CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | Not published | Not published |
| TRAMETINIB 2MG TABLETS, 30 tablet, pack | Belfast Health and Social Care Trust | Not published | Not published |
| NHS National Framework Agreement for Omalizumab | NHS England | Not published | Not published |
| SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection | Western Health & Social Care Trust | Not published | Not published |
| PRRT (Peptide Receptor Radionuclide Therapy) | Belfast Health and Social Care Trust | Not published | Not published |
| NHS National Framework for Transition products (Axitinib and Eltrombopag) | NHS England | Not published | Not published |
| MIDOSTAURIN 25MG CAPSULES | Northern Health and Social Care Trust | Not published | Not published |
| Canakinumab | Northern Health and Social Care Trust | Not published | Not published |